3 completed, 1 terminated. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 3, Terminated 1 |
Follow MDD: new trials by email Literature Review of MDD trials Research Report on MDD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vortioxetine in Patients With Depression Coexisting With General Anxiety Disorder (GAD) Vortioxetine - MDD, Anxiety Disorders | Phase 4 | Completed | H. Lundbeck A/S | 100 | 2019-12-27 | 2021-04-20 |
| Effect of Bupropion on Seizure Threshold in Depressed Patients Wellbutrin SR 300Mg Extended-Release Tablet - MDD | Phase 4 | Completed | Duke University | 10 | 2017-08-25 | 2019-07-10 |
| A Six Week, Randomized, Double-Blind Placebo-Controlled, Suvorexant Augmentation Study of Antidepressant Treatment of Major Depressive Disorder With Residual Insomnia suvorexant, Placebo - Depression, Major Depressive Disorder | Phase 4 | Terminated | Institute for Advanced Medical Research, Alpharetta, GA | 32 | 2017-03-01 | 2026-11-04 |
| Glutamatergic and GABAergic Mediators of Antidepressant Response in Major Depression citalopram - MDD, Citalopram | Phase 4 | Completed | Mclean Hospital | 32 | 2012-03-01 | 2017-09-12 |
Depressive Disorder, Major (2) · Anxiety Disorders (1) · Depression (1) · Sleep Initiation and Maintenance Disorders (1)
Mental Disorders (3) · Depressive Disorder (2) · Mood Disorders (2) · Behavior (1) · Behavioral Symptoms (1) · Dyssomnias (1) · Nervous System Diseases (1) · Sleep Disorders, Intrinsic (1) · Sleep Wake Disorders (1)
Bupropion (1) · Citalopram (1) · Vortioxetine (1) · suvorexant (1)
Duke University (1) · H. Lundbeck A/S (1) · Institute for Advanced Medical Research, Alpharetta, GA (1) · Mclean Hospital (1)
United States (3) · Estonia (1) · France (1) · Italy (1) · Poland (1) · South Korea (1) · Spain (1)
Angelo Sambunaris, MD (1) · Brian P. Brennan, M.D. (1) · Steven Szabo, MD PhD (1)